Cape Investment Advisory’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Cape Investment Advisory's VRTX Position: Q2 2026 in Review
Cape Investment Advisory opened a new position in Vertex Pharmaceuticals (VRTX) in Q2 2026: 181 shares worth $89.9K. The stake represents 0.02% of the portfolio and ranks #365 among its holdings. This is a return to the name: Cape Investment Advisory previously reported a position in VRTX as recently as Q4 2025.
Cape Investment Advisory first reported a position in VRTX in Q1 2023 and has held it in 13 quarters since. The position peaked at $104K in Q4 2023. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Cape Investment Advisory held 181 shares of Vertex Pharmaceuticals worth $89.9K as of Q2 2026.
- Vertex Pharmaceuticals was a new Cape Investment Advisory position in Q2 2026.
- Vertex Pharmaceuticals made up 0.02% of Cape Investment Advisory's portfolio in Q2 2026, its #365 holding.
- Cape Investment Advisory first reported a position in Vertex Pharmaceuticals in Q1 2023 and has held it in 13 quarters since.
- Cape Investment Advisory's Vertex Pharmaceuticals position peaked at $104K in Q4 2023.
- 1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Cape Investment Advisory's 13F filing for Q2 2026, filed 23 Jul 2026.